<DOC>
	<DOCNO>NCT02265068</DOCNO>
	<brief_summary>Documentation long-term data regard ticagrelor use evaluation reason discontinuation ticagrelor patient ACS</brief_summary>
	<brief_title>Real Life Long-term Adherence Ticagrelor After PCI Acute Coronary Syndromes</brief_title>
	<detailed_description>REAL-TICA retrospective non-interventional study ass long-term use ticagrelor patient ACS evaluate reason discontinuation ticagrelor . For purpose , select site ALKK-PCI registry respective patient identify . The site ' eligibility study include frequent use ticagrelor acute phase ACS . Eligible patient characterise diagnosis ACS use ticagrelor PCI . The eligible site contact IHF ask contact eligible patient letter obtain informed consent patient plan 12M follow-up IHF . A detailed questionnaire event within last 12 month , current symptom , current medication use ticagrelor add patient ' letter . Patients ask return response consent participate study well fill questionnaire IHF . Alternatively , patient may choose receive telephone call IHF answer detail questionnaire person . In case essential information miss , IHF contact primary care physician patient directly obtain information clinical event medication .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Age &gt; 18 ACS ( STEMI NSTEACS ) PCI Ticagrelor treatment acute phase Written inform consent participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute coronary syndrome ( ACS ) , Ticagrelor</keyword>
</DOC>